- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes mellitus and metformin in hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 27, Pages 6100
Publisher
Baishideng Publishing Group Inc.
Online
2016-07-26
DOI
10.3748/wjg.v22.i27.6100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
- (2016) Younak Choi et al. Cancer Research and Treatment
- Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
- (2015) Andrea Casadei Gardini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology
- (2015) Tetsuhiro Chiba et al. HEPATOLOGY RESEARCH
- Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
- (2015) SHINTARO FUJIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
- (2015) Hamza Chettouh et al. LIVER INTERNATIONAL
- Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies
- (2015) TAKAYUKI FUJIMORI et al. ONCOLOGY REPORTS
- The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin
- (2015) KIYOHITO KATO et al. ONCOLOGY REPORTS
- Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers
- (2015) Susan B. Brown et al. STEROIDS
- Research progress and prospects of markers for liver cancer stem cells
- (2015) Cheng-Pei Zhu WORLD JOURNAL OF GASTROENTEROLOGY
- Short- and long-term outcomes of hepatectomy with or without radiofrequency-assist for the treatment of hepatocellular carcinomas: a retrospective comparative cohort study
- (2015) Rui Guo et al. BioScience Trends
- Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo
- (2015) Xianbin Cai et al. PLoS One
- Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
- (2014) Sean F Altekruse et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
- (2014) Jisun Kim et al. BMC CANCER
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
- (2014) Jessica L. Harding et al. DIABETES CARE
- Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
- (2014) Xiaodan Zhang et al. HEPATOLOGY
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- miRNA in hepatocellular carcinoma
- (2014) Asahiro Morishita et al. HEPATOLOGY RESEARCH
- Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study
- (2014) Chia-Ing Li et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
- (2014) HISAAKI MIYOSHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of estrogen in hepatocellular carcinoma: is inflammation the key?
- (2014) Liang Shi et al. Journal of Translational Medicine
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
- (2014) Yan-Gang Wang et al. PLoS One
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle
- (2013) Jacqueline M. Major et al. ANNALS OF EPIDEMIOLOGY
- Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003
- (2013) Hideo Tanaka et al. ANNALS OF INTERNAL MEDICINE
- Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- (2013) S. Schlesinger et al. ANNALS OF ONCOLOGY
- Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
- (2013) W-P Koh et al. BRITISH JOURNAL OF CANCER
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Diabetes and cancer: two diseases with obesity as a common risk factor
- (2013) S. K. Garg et al. DIABETES OBESITY & METABOLISM
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
- (2013) Hao Yang et al. HEPATOLOGY
- Obesity, adipokines and hepatocellular carcinoma
- (2013) Xiao-Feng Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status
- (2013) Shigetoshi Naito et al. LIVER INTERNATIONAL
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
- (2013) Mary Jo Cantoria et al. Metabolomics
- Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2013) M. Yin et al. ONCOLOGIST
- Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo
- (2013) XIANBIN CAI et al. ONCOLOGY REPORTS
- Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
- (2013) Tomoko Saito et al. PLoS One
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
- (2012) Shanchun Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2012) Weiguang Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
- (2012) R. J. Stevens et al. DIABETOLOGIA
- Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
- (2012) J. A. Johnson et al. DIABETOLOGIA
- MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression
- (2012) Akemi Takata et al. HEPATOLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Antitumor effect of metformin in esophageal cancer: In vitro study
- (2012) MITSUYOSHI KOBAYASHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
- (2012) Kiyoshi Hasegawa et al. JOURNAL OF HEPATOLOGY
- The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
- (2012) K. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
- (2012) Ana Chocarro-Calvo et al. MOLECULAR CELL
- Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
- (2011) Shih-Wei Lai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
- (2011) Ben-Xu Tan et al. CANCER
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
- (2011) Ping Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
- (2011) J. A. Johnson et al. DIABETOLOGIA
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- (2011) Jin Ha Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
- (2011) Hirokazu Takahashi et al. JOURNAL OF GASTROENTEROLOGY
- Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
- (2011) Hans-Werner Hense et al. Diabetology & Metabolic Syndrome
- Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
- (2011) Susen Becker et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11)
- (2010) Gijs W Landman et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer
- (2010) X. L. Yang et al. DIABETOLOGIA
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
- (2010) P. D. Home et al. DIABETOLOGIA
- Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
- (2010) Anna S. Lok et al. GASTROENTEROLOGY
- No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus
- (2010) Andrea Snow-Lampart et al. HEPATOLOGY
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
- (2009) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Insulin, insulin-like growth factors and neoplasia
- (2008) Michael Pollak BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
- (2008) D. M. Nathan et al. DIABETOLOGIA
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
- (2008) Patrick Marcellin et al. HEPATOLOGY
- Global burden of obesity in 2005 and projections to 2030
- (2008) T Kelly et al. INTERNATIONAL JOURNAL OF OBESITY
- Liver Cancer Stem Cells
- (2008) Stewart Sell et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Stem Cells: A Step Toward the Cure
- (2008) Bruce M. Boman et al. JOURNAL OF CLINICAL ONCOLOGY
- Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis
- (2008) Yusuke Kawamura et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Warburg revisited: imaging tumour blood flow and metabolism
- (2008) K.A. Miles CANCER IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now